Use of intravenous immunoglobulins in clinical practice: Data from three French university hospitals

Fundamental and Clinical Pharmacology

Volumn 25, Issue 6, 2011, Pages 753-761

  Frauger, Elisabeth ^a   Grassi, Jerome ^a   Pradel, Vincent ^a   Bornet, Charleric ^a   Rouby, Frank ^a   Delorme, Jean ^a   Ousset, Sebastien ^a   Braguer, Diane ^a   Azulay, Jean Philippe ^a   Penot Ragon, Christine ^a   Harle, Jean Robert ^a   Bongrand, Marie Claude ^a   Weiller, Pierre Jean ^a   Pouget, Jean ^a   Michel, Gérard ^a   Micallef, Joelle ^a   Reynier, Jean Pierre ^a   Tardieu, Sophie ^a   Vanelle, Patrice ^a   Blin, Olivier ^b   André, Ali Cherif ^c   Jean Pierre, Auffray ^c   Jean Philippe, Azulay ^c   Philippe, Berbis ^c   Yvon, Berland ^c   Bernard Jean, Blanc ^c   Jean Jacques, Bonerandi ^c   Marie Claude, Bonerandi ^c   Charleric, Bornet ^c   Leon B Boubli ^c   Jean Philippe, Boulenger ^c   Diane, Braguer ^c   Claudette, Briand ^c   Jean, Camboulives ^c   Corinne, Chabrieres ^c   Hervé, Chambost ^c   Denis, Charpin ^c   Patrick, Dalmas ^c   Jean, Delorme ^c   Roger, Favre ^c   Yves, Frances ^c   Hervé, Gallais ^c   Marc, Gamerre ^c   Jean Marc, Garnier ^c   Jean Louis, Gastaut ^c   Brigitte, Chabrol ^c   François, Gouin ^c   Jerome, Grassi ^c   Nicole, Grimaldi ^c   Jean Charles, Grimaud ^c   Jean Jacques, Grob ^c   Jean Robert, Harle ^c   Marc, Heim ^c   Sylvie, Hesse ^c   Philippe, Jean ^c   Yves, Le Treut ^c   Josette, Mancini ^c   Jean Claude, Manelli ^c   Gérard, Michel ^c   Sebastien, Ousset ^c   Jean, Pelletier ^c   Christine, Penot Ragon ^c   Jean Pierre, Reynier ^c   Michel, Poncet ^c   Jean, Pouget ^c   Marie Aleth, Richard ^c   Jean Marie, Sainty ^c   Jacques, Soubeyrand ^c   Patrice, Vanelle ^c   Pierre Jean, Weiller ^c   more..

^a ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^b TIMONE HOSPITAL   (France)

^c NONE

Author keywords

Drug utilization study; Hospital; Intravenous immunoglobulin

Indexed keywords

HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; CLINICAL PRACTICE; DERMATOMYOSITIS; DRUG FORMULATION; DRUG INDICATION; FEMALE; FRANCE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE DEFICIENCY; INFANT; INTERNAL MEDICINE; MAJOR CLINICAL STUDY; MALE; MOTOR NEUROPATHY; MULTIFOCAL MOTOR NEUROPATHY; NEUROLOGY; POLYRADICULONEUROPATHY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOCYTOPENIA; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FRANCE; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT; INFANT, NEWBORN; MALE; OFF-LABEL USE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; YOUNG ADULT;

EID: 80054884030     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2010.00908.x     Document Type: Article

References (28)

1. Lin M.W., Kirkpatrick P.E., Riminton D.S. How intravenous immunoglobulin is used in clinical practice: audits of two Sydney teaching hospitals. Intern. Med. J. (2007) 37 308-314.
2. Jolles S., Sewell W.A., Misbah S.A. Clinical uses of intravenous immunoglobulin. Clin. Exp. Immunol. (2005) 142 1-11.
3. El-Shanawany T., Sewell W.A., Misbah S.A. et al. Current clinical uses of intravenous immunoglobulin. Clin. Med. (2006) 6 356-359.
4. El-Shanawany T., Jolles S. Intravenous immunoglobulin and autoimmune disease. Ann. N. Y. Acad. Sci. (2007) 1110 507-515.
5. Lemieux R., Bazin R., Néron S. Therapeutic intravenous immunoglobulins. Mol. Immunol. (2005) 42 839-848.
6. Constantine M.M., Thomas W., Whitman L. et al. Intravenous immunoglobulin utilization in the Canadian Atlantic provinces: a report of the Atlantic Collaborative Intravenous Immune Globulin Utilization Working Group. Transfusion (2007) 47 2072-2080.
7. Darabi K., Abdel-Wahab O., Dzik W.H. Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature. Transfusion (2006) 46 741-753.
8. Robinson P., Anderson D., Brouwers M. et al. Evidence-based guidelines on the use of intravenous immune globulin for hematologic and neurologic conditions. Transfus. Med. Rev. (2007) 21(2 Suppl 1) S3-S8.
9. Leong H., Stachnik J., Bonk M.E. et al. Unlabeled uses of intravenous immune globulin. Am. J. Health Syst. Pharm. (2008) 65 1815-1824.
10. Pendergrast J.M., Sher G.D., Callum J.L. Changes in intravenous immunoglobulin prescribing patterns during a period of severe product shortages, 1995-2000. Vox Sang. (2005) 89 150-160.
11. Chen C., Danekas L.H., Ratko T.A. et al. A multicenter drug use surveillance of intravenous immunoglobulin utilization in US academic health centers. Ann. Pharmacother. (2000) 34 295-299.
12. Looney R.J., Huggins J. Use of intravenous immunoglobulin G (IVIG). Best Pract. Res. Clin. Haematol. (2006) 19 3-25.
13. Clinical guidelines for the use of intravenous immunoglobulin. Department of Health UK. (2008) Available from: (accessed 5 November 2009).
14. Criteria for the clinical use of intravenous immunoglobulin in Australia. Australian Health Ministers' Conference. (2007) Available from: (accessed 5 November 2009).
15. Hume H.A., Anderson D.R. Guidelines for the use of intravenous immune globulin for hematologic and neurologic conditions. Transfus. Med. Rev. (2007) 21(2 Suppl 1) S1-S2.
16. Feasby T., Banwell B., Benstead T. et al. Guidelines on the use of intravenous immune globulin for neurologic conditions. Transfus. Med. Rev. (2007) 21(2 Suppl 1) S57-S107.
17. Anderson D., Ali K., Blanchette V. et al. Guidelines on the use of intravenous immune globulin for hematologic conditions. Transfus. Med. Rev. (2007) 21(2 Suppl 1) S9-S56.
18. Enk A.; European Dermatology Forum Guideline Subcommittee. Guidelines on the use of high-dose intravenous immunoglobulin in dermatology. Eur. J. Dermatol. (2009) 19 90-98.
19. Hanna K., Poulin-Costello M., Preston M. et al. Intravenous immune globulin use in Canada. Can. J. Clin. Pharmacol. (2003) 10 11-16.
20. EMA. Guideline on the clinical investigation of human normal. Immunoglobulin for intravenous administration (IVIg). (2009) Available from: (accessed 20 October 2009).
21. ®. Available from: (accessed 22 June 2010).
22. French Health Products Agency (AFSSAPS). Guidelines for good use of immunoglobulin. Available from: (accessed 5 November 2009).
23. French Health Products Agency (AFSSAPS). Unlabelled indications for which the benefit-risk can not be assessed due to lack of current scientific evidence. Available from: (accessed 5 November 2009).
24. Courtay A., Couturon I., Charpentier E. et al. Evolution of polyvalent intravenous immunoglobulins (IVIg) prescription, at the Assistance Publique - Hopitaux de Paris between 1988 and 1997. Results of the plan of action set up in order to regulate the prescription. Ann. Med. Interne (Paris) (2000) 151(Suppl 1) 1S5-1S12.
25. Presentation of the CEDIT. Available from: (accessed 20 December 2010).
26. Guillevin L. Indications for immunoglobulins. Recommendations of CEDIT of AP-HP in 2006. Rev. Med. Interne (2007) 28(No. 1) 1-3.
27. Pradel V., Tardieu S., Micallef J. et al. Use of albumin in three French university hospitals: is prescription monitoring still useful in 2004? Pharmacoepidemiol. Drug Saf. (2007) 16 79-85.
28. Griffin J.W., Hughes R.A. Intravenous immunoglobulin for neuromuscular disease: costs, benefits and reimbursement. Nat. Clin. Pract. Neurol. (2009) 5 119.